Exosomes: An overview of biogenesis, composition and role in ovarian cancer

Journal of Ovarian Research

Volumn 7, Issue 1, 2014, Pages

  Beach, Allison ^a   Zhang, Huang Ge ^b   Ratajczak, Mariusz Z ^b   Kakar, Sham S ^b  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cancer; Cancer diagnosis; Exosome; Microvesicle; Ovarian cancer

Indexed keywords

BIOGENESIS; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL FUNCTION; EXOSOME; HUMAN; IMMUNOLOGICAL TOLERANCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; ANIMAL; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; OVARIAN NEOPLASMS; PATHOLOGY; PREDICTIVE VALUE; SIGNAL TRANSDUCTION; TUMOR ESCAPE;

MICRORNA; TUMOR MARKER; TUMOR PROTEIN;

ANIMALS; EXOSOMES; FEMALE; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; SIGNAL TRANSDUCTION; TUMOR ESCAPE; TUMOR MARKERS, BIOLOGICAL;

EID: 84896735649     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-7-14     Document Type: Review

References (97)

1. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Trams EG, Lauter CJ, Salem N Jr, Heine U, Biochim Biophys Acta 1981 645 63 70 10.1016/0005-2736(81)90512-5 6266476
2. Electron microscopic evidence for xternalization of the transferrin receptor in vesicular form in sheep reticulocytes. Pan BT, Teng K, Wu C, Adam M, Johnstone RM, J Cell Biol 1985 101 942 948 10.1083/jcb.101.3.942 2993317 (Pubitemid 16256847)
3. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C, J Biol Chem 1987 262 9412 9420 3597417
4. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Johnstone RM, Bianchini A, Teng K, Blood 1989 74 1844 1851 2790208 (Pubitemid 19251570)
5. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. Harding C, Heuser J, Stahl P, J Cell Biol 1983 97 329 39 10.1083/jcb.97.2.329 6309857
6. Exosomes with immune modulatory features are present in human breast milk. Admyre C, Johansson SM, Qazi KR, Filén JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S, J Immunol 2007 179 1969 1978 17641064
7. Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. Masyuk AI, Masyuk TV, Larusso NF, J Hepatol 2013 59 621 625 10.1016/j.jhep.2013.03.028 23557871
8. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF, Eur Biophys J 2008 37 323 332 10.1007/s00249-007-0246-z 18064447
9. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN, Am J Respir Cell Mol Biol 2004 31 114 21 10.1165/rcmb.2003-0238OC 14975938 (Pubitemid 38888047)
10. Exosome function: from tumor immunology to pathogen biology. Schorey JS, Bhatnagar S, Traffic 2008 9 871 881 10.1111/j.1600-0854.2008.00734.x 18331451 (Pubitemid 351639493)
11. Purification, characterization and biological significance of tumor-derived exosomes. Koga K, Matsumoto K, Akiyoshi T, Kubo M, Yamanaka N, Tasaki A, Nakashima H, Nakamura M, Kuroki S, Tanaka M, Katano M, Anticancer Res 2005 25 3703 3707 16302729 (Pubitemid 41658442)
12. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Taylor DD, Gercel-Taylor C, Gynecol Oncol 2008 110 13 21 10.1016/j.ygyno.2008.04.033 18589210 (Pubitemid 351853251)
13. Exosomes: composition, biogenesis and function. Théry C, Zitvogel L, Amigorena S, Nat Rev Immunol 2002 2 569 579 12154376 (Pubitemid 37328732)
14. Exosomes: from biogenesis and secretion to biological function. Keller S, Sanderson MP, Stoeck A, Altevogt P, Immunol Lett 2006 107 102 108 10.1016/j.imlet.2006.09.005 17067686 (Pubitemid 44779821)
15. Exosomes: A Common Pathway for a Specialized Function. van Niel G, Porto-Carreiro I, Simoes S, Raposo G, J. Biochem 2006 140 13 21 10.1093/jb/mvj128 16877764 (Pubitemid 44433541)
16. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. Théry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S, J Cell Biol 1999 147 599 610 10.1083/jcb.147.3.599 10545503 (Pubitemid 29523465)
17. Exosomes-vesicular carriers for intercellular communication. Simons M, Raposo G, Curr Opin Cell Biol 2009 21 575 81 10.1016/j.ceb.2009.03.007 19442504
18. A common mechanism may be involved in the selective loss of plasma membrane functions during reticulocyte maturation. Johnstone RM, Ahn J, Biomed Biochim Acta 1990 49 70 S75 2386531
19. The genomic and proteomic content of cancer cell-derived exosomes. Henderson MC, Azorsa DO, Front Oncol 2012 2 38 22649786
20. Tumor-exosomes and leukocyte activation: an ambivalent crosstalk. Zech D, Rana S, Büchler MW, Zöller M, Cell Commun Signal 2012 10 37 10.1186/1478-811X-10-37 23190502
21. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK, Stem Cell Res 2010 4 214 222 10.1016/j.scr.2009.12.003 20138817
22. Intestinal epithelial exosomes carry MHC class II/peptides able to inform the immune system in mice. Van Niel G, Mallegol J, Bevilacqua C, Candalh C, Brugière S, Tomaskovic-Crook E, Heath JK, Cerf-Bensussan N, Heyman M, Gut 2003 52 1690 1697 10.1136/gut.52.12.1690 14633944 (Pubitemid 37510387)
23. Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN, Arthritis Rheum 2005 52 1517 1521 10.1002/art.21005 15880835 (Pubitemid 40663943)
24. Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4): potential mechanism of apoptosis induction in Alzheimer disease (AD). Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, Mayer-Proschel M, Bieberich E, J Biol Chem 2012 287 21384 1395 10.1074/jbc.M112.340513 22532571
25. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway nvolving exosomes. Zhan R, Leng X, Liu X, Wang X, Gong J, Yan L, Wang L, Wang Y, Wang X, Qian LJ, Biochem Biophys Res Commun 2009 387 229 233 10.1016/j.bbrc.2009.06.095 19555663
26. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. Keryer-Bibens C, Pioche-Durieu C, Villemant C, Souquère S, Nishi N, Hirashima M, Middeldorp J, Busson P, BMC Cancer 2006 6 283 10.1186/1471-2407-6- 283 17156439 (Pubitemid 46218055)
27. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. Savina A, Furlán M, Vidal M, Colombo MI, J Biol Chem 2003 278 20083 20090 10.1074/jbc.M301642200 12639953 (Pubitemid 36799202)
28. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Navabi H, Croston D, Hobot J, Clayton A, Zitvogel L, Jasani B, Bailey-Wood R, Wilson K, Tabi Z, Mason MD, Adams M, Blood Cells Mol Dis 2005 35 149 152 10.1016/j.bcmd.2005.06.008 16061407 (Pubitemid 41267042)
29. Exosomal microRNA: a diagnostic marker for lung cancer. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH, Clin Lung Cancer 2009 10 1 42 46 10.3816/CLC.2009.n.006 19289371
30. Profiling of microRNAs in exosomes released from PC-3 prostate cancer cells. Hessvik NP, Phuyal S, Brech A, Sandvig K, Llorente A, Biochim Biophys Acta 1819 2012 1154 1163
31. Changes in circulating microRNA levels associated with prostate cancer. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, Kuslich C, Visakorpi T, Hamdy FC, Br J Cancer 2012 106 768 774 10.1038/bjc.2011.595 22240788
32. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, Ikeda N, Isozaki Y, Maruyama T, Akanuma N, Komatsu A, Jitsukawa M, Matsubara H, Br J Cancer 2013 108 644 652 10.1038/bjc.2013.8 23361059
33. Malignant effusions and immunogenic tumour-derived exosomes. AAndre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L, Lancet 2002 360 295 305 10.1016/S0140-6736(02)09552-1 12147373 (Pubitemid 34874721)
34. Exosomes: a bubble ride for prions? Février B, Vilette D, Laude H, Raposo G, Traffic 2005 6 10 17 10.1111/j.1600-0854.2004.00247.x 15569241
35. Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE, Proteomics 2004 4 4019 4031 10.1002/pmic.200400876 15478216 (Pubitemid 39657475)
36. Tolerosomes are produced by intestinal epithelial cells. Karlsson M, Lundin S, Dahlgren U, Kahu H, Pettersson I, Telemo E, Eur J Immunol 2001 31 2892 2900 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I 11592064 (Pubitemid 32994540)
37. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L, Nat Med 2001 7 297 303 10.1038/85438 11231627 (Pubitemid 32224344)
38. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Keller S, Rupp C, Stoeck A, Runz S, Fogel M, Lugert S, Hager HD, Abdel-Bakky MS, Gutwein P, Altevogt P, Kidney Int 2007 72 1095 1102 10.1038/sj.ki.5002486 17700640 (Pubitemid 47609042)
39. Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment. Li QL, Bu N, Yu YC, Hua W, Xin XY, Clin Med Oncol 2008 2 461 467 21892318
40. Serum-derived exosomes from antigen-fed mice prevent allergic sensitization in a model of allergic asthma. Almqvist N, Lönnqvist A, Hultkrantz S, Rask C, Telemo E, Immunology 2008 125 21 27 10.1111/j.1365-2567. 2008.02812.x 18355242
41. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. Gallo A, Tandon M, Alevizos I, Illei GG, PLoS One 2012 7 30679 10.1371/journal.pone.0030679 22427800
42. Exosome-like vesicles with dipeptidyl peptidase IV in human saliva. Ogawa Y, Kanai-Azuma M, Akimoto Y, Kawakami H, Yanoshita R, Biol Pharm Bull 2008 31 6 1059 1062 10.1248/bpb.31.1059 18520029 (Pubitemid 351871149)
43. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G, Altevogt P, Gynecol Oncol 2007 107 563 571 10.1016/j.ygyno.2007.08.064 17900673 (Pubitemid 350160873)
44. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, Jackson B, McKee AC, Alvarez VE, Lee NC, Hall GF, J Biol Chem 2012 287 3842 3849 10.1074/jbc.M111.277061 22057275
45. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RT, Webb DJ, Dear JW, J Transl Med 2012 10 5 10.1186/1479-5876-10-5 22221959
46. Antigen-specific activities of CD8+ T cells in the nasal mucosa of patients with nasal allergy. Qiu S, Duan X, Geng X, Xie J, Gao H, Asian Pac J Allergy Immunol 2012 30 107 13 22830289
47. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi E, Brambilla D, Venturi G, Lozupone F, Santinami M, Huber V, Maio M, Rivoltini L, Fais S, PLoS One 2009 4 5219 10.1371/journal.pone.0005219 19381331
48. Exosomes as ntercellular signalosomes and pharmacological effectors. Record M, Subra C, Silvente-Poirot S, Poirot M, Biochem Pharmacol 2011 81 1171 1182 10.1016/j.bcp.2011.02.011 21371441
49. Exosomal Lipids in Cell-Cell Communication. Record M, Emerging Concepts of Tumor Exosome-Mediated Cell-Cell Communication New York, NY USA: Springer, Zhang H-G, 2013 47 68
50. Rab27a and Rab27b control different steps of the exosome secretion pathway. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C, Nat Cell Biol 2010 12 1-13 19 30 19966785
51. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Grønborg M, Möbius W, Rhee J, Barr FA, Simons M, J Cell Biol 2010 189 223 32 10.1083/jcb.200911018 20404108
52. The exosome pathway in K562 cells is regulated by Rab11. Savina A, Vidal M, Colombo MI, J Cell Sci 2002 115 2505 2515 12045221 (Pubitemid 34778068)
53. The regulation of exosome secretion: a novel function of the p53 protein. Yu X, Harris SL, Levine AJ, Cancer Res 2006 66 4795 4801 10.1158/0008-5472.CAN- 05-4579 16651434
54. The regulation of the endosomal compartment by p53 the tumor suppressor gene. Yu XT, Riley T, Levine AJ, FEBS J 2009 276 2201 2212 10.1111/j.1742-4658. 2009.06949.x 19302216
55. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Azmi AS, Bao B, Sarkar FH, Cancer Metastasis Rev 2013 Epub ahead of print
56. Microenvironmental pH is a key factor for exosome traffic in tumor cells. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, De Milito A, Coscia C, Iessi E, Logozzi M, Molinari A, Colone M, Tatti M, Sargiacomo M, Fais S, J Biol Chem 2009 284 34211 34222 10.1074/jbc.M109.041152 19801663
57. The biogenesis and functions of exosomes. Stoorvogel W, Kleijmeer MJ, Geuze HJ, Raposo G, Traffic 2002 3 321 330 10.1034/j.1600-0854.2002.30502.x 11967126 (Pubitemid 34461042)
58. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Keller S, König AK, Marmé F, Runz S, Wolterink S, Koensgen D, Mustea A, Sehouli J, Altevogt P, Cancer Lett 2009 278 73 81 10.1016/j.canlet.2008.12.028 19188015
59. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ, Nucleic Acids Res 2012 40 1241 D1244 10.1093/nar/gkr828 21989406
60. ExoCarta: A compendium of exosomal proteins and RNA. Mathivanan S, Simpson RJ, Proteomics 2009 9 4997 5000 10.1002/pmic.200900351 19810033
61. Production and characterization of clinical grade exosomes derived from dendritic cells. Lamparski HG, Metha-Damani A, Yao JY, Patel S, Hsu DH, Ruegg C, Le Pecq JB, J Immunol Methods 2002 270 211 226 10.1016/S0022-1759(02)00330-7 12379326
62. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Cho JA, Park H, Lim EH, Lee KW, Int J Cancer 2005 114 613 622 10.1002/ijc.20757 15609328 (Pubitemid 40349621)
63. Proteomic analysis of exosomes secreted by human mesothelioma cells. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, Zitvogel L, Burgers SA, Hoogsteden HC, Lambrecht BN, Am J Pathol 2004 164 1807 1815 10.1016/S0002-9440(10)63739-X 15111327 (Pubitemid 38529783)
64. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Nat Cell Biol 2007 9 654 659 10.1038/ncb1596 17486113 (Pubitemid 47214727)
65. Exosome isolation for proteomic analyses and RNA profiling. Taylor DD, Zacharias W, Gercel-Taylor C, Methods Mol Biol 2011 728 235 246 10.1007/978-1-61779-068-3-15 21468952
66. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM, Nature 2005 433 769 773 10.1038/nature03315 15685193 (Pubitemid 40292988)
67. Non-coding RNAs: regulators of disease. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS, J Pathol 2010 220 126 139 10.1002/path.2638 19882673
68. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim J, Kim JH, Choi DS, Kim YK, Hwang D, Gho YS, BMC Genomics 2009 10 556 10.1186/1471-2164-10-556 19930720
69. Intercellular Communication by Exosome-Derived microRNAs in Cancer. Hannafon BN, Ding WQ, Int J Mol Sci 2013 14 14240 14269 10.3390/ijms140714240 23839094
70. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ, Leukemia 2006 20 847 56 10.1038/sj.leu.2404132 16453000
71. Exosomes: endosomal-derived vesicles shipping extracellular messages. Fevrier B, Raposo G, Curr Opin Cell Biol 2004 16 415 421 10.1016/j.ceb.2004.06. 003 15261674 (Pubitemid 38903148)
72. Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Taylor DD, Gercel-Taylor C, Semin Immunopathol 2011 33 441 54 10.1007/s00281-010-0234-8 21688197
73. Characterization and proteomic analysis of ovarian cancer-derived exosomes. Liang B, Peng P, Chen S, Li L, Zhang M, Cao D, Yang J, Li H, Gui T, Li X, Shen K, Proteomics 2013 80C 171 182 23333927
74. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Taylor DD, Gerçel-Taylor C, Br J Cancer 2005 92 305 311 15655551 (Pubitemid 40343146)
75. Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity. Peng P, Yan Y, Keng S, Oncol Rep 2011 25 749 762 21181093
76. The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Taylor DD, Gercel-Taylor C, Front Genet 2013 4 142 23908664
77. Frequent EpCam protein expression in human carcinomas. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S, Hum Pathol 2004 35 122 128 10.1016/j.humpath.2003.08.026 14745734 (Pubitemid 38133932)
78. Modulation of maternal immune system during pregnancy in the cow. Oliveira LJ, Barreto RS, Perecin F, Mansouri-Attia N, Pereira FT, Meirelles FV, Reprod Domest Anim 2012 47 Suppl 4 384 393 22827396
79. Human placental trophoblasts confer viral resistance to recipient cells. Delorme-Axford E, Donker RB, Mouillet JF, Chu T, Bayer A, Ouyang Y, Wang T, Stolz DB, Sarkar SN, Morelli AE, Sadovsky Y, Coyne CB, Proc Natl Acad Sci USA 2013 110 12048 12053 10.1073/pnas.1304718110 23818581
80. Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity. Williams JL, Gatson NN, Smith KM, Almad A, McTigue DM, Whitacre CC, Clin Immunol 2013 149 236 243 10.1016/j.clim.2013. 04.005 23706172
81. Pregnancy-associated exosomes and their modulation of T cell signaling. Taylor DD, Akyol S, Gercel-Taylor C, J Immunol 2006 176 1534 1542 16424182 (Pubitemid 43134297)
82. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Pêche H, Heslan M, Usal C, Amigorena S, Cuturi MC, Transplantation 2003 76 1503 1510 10.1097/01.TP.0000092494.75313.38 14657694 (Pubitemid 37467702)
83. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG, J Immunol 2006 176 1375 1385 16424164 (Pubitemid 43134279)
84. TLR2-mediated expansion of MDSCs is dependent on the source of tumor exosomes. Xiang X, Liu Y, Zhuang X, Zhang S, Michalek S, Taylor DD, Grizzle W, Zhang HG, Am J Pathol 2010 177 1606 1610 10.2353/ajpath.2010.100245 20802178
85. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z, Cancer Res 2007 67 7458 7466 10.1158/0008-5472.CAN-06-3456 17671216 (Pubitemid 47214451)
86. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak MZ, Transfusion. 2006 46 1199 209 10.1111/j.1537-2995. 2006.00871.x 16836568 (Pubitemid 44139495)
87. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, Min WP, Blood Cells Mol Dis 2005 35 169 173 10.1016/j.bcmd.2005.07.001 16081306 (Pubitemid 41267045)
88. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. Viaud S, Terme M, Flament C, Taieb J, André F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T, Zitvogel L, Chaput N, PLoS One 2009 4 4942 10.1371/journal.pone.0004942 19319200
89. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK, J Transl Med 2005 3 9 10.1186/1479-5876-3-9 15723705 (Pubitemid 40617870)
90. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Admyre C, Grunewald J, Thyberg J, Gripenbäck S, Tornling G, Eklund A, Scheynius A, Gabrielsson S, Eur Respir J 2003 22 578 583 10.1183/09031936.03.00041703 14582906 (Pubitemid 37258532)
91. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk. Abu Saadeh F, Norris L, O'Toole S, Mohamed BM, Langhe R, O'Leary J, Gleeson N, Thromb Res 2013 132 627 634 10.1016/j.thromres.2013.09.016 24094893
92. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ, Int J Cancer 2005 113 752 60 10.1002/ijc.20657 15499615 (Pubitemid 40101256)
93. Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Wysoczynski M, Liu R, Kucia M, Drukala J, Ratajczak MZ, Mol Cancer Res 2010 8 677 90 10.1158/1541-7786.MCR-10- 0019 20442298
94. Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Wysoczynski M, Ratajczak MZ, Int J Cancer 2009 125 1595 603 10.1002/ijc.24479 19462451
95. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Wang B, Zhuang X, Deng ZB, Jiang H, Mu J, Wang Q, Xiang X, Guo H, Zhang L, Dryden G, Yan J, Miller D, Zhang HG, Mol Ther 2013
96. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, Xiang X, Deng ZB, Wang B, Zhang L, Roth M, Welti R, Mobley J, Jun Y, Miller D, Zhang HG, Mol Ther 2013 21 1345 1357 10.1038/mt.2013.64 23752315
97. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Wang Q, Zhuang X, Mu J, Deng ZB, Jiang H, Zhang L, Xiang X, Wang B, Yan J, Miller D, Zhang HG, Nat Commun 1867 2013 4